IHS Chemical Week

Chemical Week Magazine :: Pharmaceuticals & Fine Chemicals

Ranbaxy Recalls Antibiotic in U.S.

9:59 AM MDT | May 8, 2009

Ranbaxy Pharmaceuticals, a Ranbaxy Laboratories (Gurgaon, India) subsidiary, says it has voluntarily recalled its antibiotic nitrofurantoin capsules from the U.S. market, as certain lots of the product did not conform with approved laboratory specifications. The recall is being coordinated with the U.S. FDA and will be on a retail level, Ranbaxy says. The company says it is looking into the cause of the non-conformity, and that the recalled products are unlikely to produce any serious adverse health effects. However, the company says there is a “remote...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa